Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Sep 30, 2024

BUY
$21.54 - $24.41 $1.43 Million - $1.63 Million
66,595 New
66,595 $1.51 Million
Q3 2023

Nov 06, 2023

SELL
$21.54 - $24.41 $86.3 Million - $97.7 Million
-4,004,491 Reduced 98.36%
66,595 $1.51 Million
Q2 2023

Sep 27, 2024

SELL
$12.62 - $24.47 $1.34 Million - $2.61 Million
-106,559 Reduced 2.55%
4,071,086 $99.6 Million
Q2 2023

Jul 19, 2023

SELL
$12.62 - $24.47 $1.34 Million - $2.61 Million
-106,559 Reduced 2.55%
4,071,086 $99.6 Million
Q1 2023

Sep 27, 2024

BUY
$12.98 - $17.1 $54.2 Million - $71.4 Million
4,177,645 New
4,177,645 $56.2 Million
Q1 2023

May 11, 2023

BUY
$12.98 - $17.1 $1.06 Million - $1.39 Million
81,295 Added 1.98%
4,177,645 $56.2 Million
Q4 2022

Sep 27, 2024

BUY
$13.92 - $17.0 $57 Million - $69.6 Million
4,096,350 New
4,096,350 $63.7 Million
Q4 2022

Feb 10, 2023

BUY
$13.92 - $17.0 $51.3 Million - $62.6 Million
3,683,164 Added 891.41%
4,096,350 $63.7 Million
Q3 2022

Nov 07, 2022

SELL
$13.36 - $16.75 $199,210 - $249,759
-14,911 Reduced 3.48%
413,186 $6.19 Million
Q2 2022

Jul 27, 2022

BUY
$12.69 - $19.25 $1.29 Million - $1.96 Million
101,844 Added 31.22%
428,097 $6.19 Million
Q1 2022

May 12, 2022

BUY
$15.5 - $23.89 $172,422 - $265,752
11,124 Added 3.53%
326,253 $5.97 Million
Q4 2021

Feb 10, 2022

BUY
$20.04 - $23.84 $33,607 - $39,979
1,677 Added 0.54%
315,129 $7.42 Million
Q3 2021

Nov 12, 2021

BUY
$17.38 - $21.54 $3.57 Million - $4.42 Million
205,223 Added 189.62%
313,452 $6.35 Million
Q2 2021

Aug 09, 2021

BUY
$18.47 - $22.11 $1.54 Million - $1.84 Million
83,303 Added 334.2%
108,229 $2.06 Million
Q1 2021

May 13, 2021

BUY
$19.22 - $24.3 $196,120 - $247,957
10,204 Added 69.31%
24,926 $479,000
Q4 2020

Feb 11, 2021

BUY
$18.2 - $22.45 $267,940 - $330,508
14,722 New
14,722 $317,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Jarislowsky, Fraser LTD Portfolio

Follow Jarislowsky, Fraser LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.